imagequant software version 5 2 (Molecular Dynamics Inc)
Structured Review
Imagequant Software Version 5 2, supplied by Molecular Dynamics Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/imagequant+software+version+5%C2%B72/imagequant+software/pmc11012841-164-36-40
Average 86 stars, based on 1 article reviews
Images
Related Articles
Western Blot:Article Title: Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice. Article Snippet: Background Four cardiac hormones synthesized by the same gene, i.e. atrial natriuretic peptide, vessel dilator, long acting natriuretic peptide and kaliuretic peptide, and the kidney hormone urodilatin have anticancer effects in vitro.. Materials and Methods These cardiac hormones and urodilatin were infused subcutaneously for 28 days with weekly fresh hormones since they lose biological effects at body temperature for more than a week at 0·3 nM kg body weight in athymic mice bearing human small-cell lung carcinomas.. Results Long acting natriuretic peptide, vessel dilator, kaliuretic peptide, atrial natriuretic peptide and urodilatin eliminated 86%, 71%, 57%, 43% (P < 0·001 for the cardiac hormones) and 25% (P < 0·05; urodilatin) of the human small-cell lung carcinomas. Software:Article Title: Cardiac and kidney hormones cure up to 86% of human small-cell lung cancers in mice. Article Snippet: Background Four cardiac hormones synthesized by the same gene, i.e. atrial natriuretic peptide, vessel dilator, long acting natriuretic peptide and kaliuretic peptide, and the kidney hormone urodilatin have anticancer effects in vitro.. Materials and Methods These cardiac hormones and urodilatin were infused subcutaneously for 28 days with weekly fresh hormones since they lose biological effects at body temperature for more than a week at 0·3 nM kg body weight in athymic mice bearing human small-cell lung carcinomas.. Results Long acting natriuretic peptide, vessel dilator, kaliuretic peptide, atrial natriuretic peptide and urodilatin eliminated 86%, 71%, 57%, 43% (P < 0·001 for the cardiac hormones) and 25% (P < 0·05; urodilatin) of the human small-cell lung carcinomas. |
